140 related articles for article (PubMed ID: 12550767)
1. Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.
van Dartel M; Cornelissen PW; Redeker S; Tarkkanen M; Knuutila S; Hogendoorn PC; Westerveld A; Gomes I; Bras J; Hulsebos TJ
Cancer Genet Cytogenet; 2002 Dec; 139(2):91-6. PubMed ID: 12550767
[TBL] [Abstract][Full Text] [Related]
2. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
[TBL] [Abstract][Full Text] [Related]
3. Infrequent but high-level amplification of 17p11.2 approximately p12 in human glioma.
van Dartel M; Leenstra S; Troost D; Hulsebos TJ
Cancer Genet Cytogenet; 2003 Jan; 140(2):162-6. PubMed ID: 12645656
[TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
Both J; Wu T; Bras J; Schaap GR; Baas F; Hulsebos TJ
PLoS One; 2012; 7(1):e30907. PubMed ID: 22292074
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human Osteosarcoma.
Both J; Wu T; Ten Asbroek AL; Baas F; Hulsebos TJ
Cytogenet Genome Res; 2016; 150(1):52-59. PubMed ID: 27846620
[TBL] [Abstract][Full Text] [Related]
7. Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas.
Hulsebos TJ; Bijleveld EH; Oskam NT; Westerveld A; Leenstra S; Hogendoorn PC; Bras J
Genes Chromosomes Cancer; 1997 Apr; 18(4):279-85. PubMed ID: 9087567
[TBL] [Abstract][Full Text] [Related]
8. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
9. SAS is amplified predominantly in surface osteosarcoma.
Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
[TBL] [Abstract][Full Text] [Related]
10. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
[TBL] [Abstract][Full Text] [Related]
11. Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis.
Simons A; Janssen IM; Suijkerbuijk RF; Veth RP; Pruszczynski M; Hulsbergen-van de Kaa CA; du Manoir S; Geurts van Kessel A
Genes Chromosomes Cancer; 1997 Oct; 20(2):196-200. PubMed ID: 9331570
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
[TBL] [Abstract][Full Text] [Related]
13. Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma.
Johnson-Pais TL; Nellissery MJ; Ammerman DG; Pathmanathan D; Bhatia P; Buller CL; Leach RJ; Hansen MF
Int J Cancer; 2003 Jun; 105(2):285-8. PubMed ID: 12673693
[TBL] [Abstract][Full Text] [Related]
14. TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A; Salas S; Bertucci F; Sobinoff AP; Adélaïde J; Guille A; Finetti P; Noble JR; Churikov D; Chaffanet M; Lavit E; Pickett HA; Bouvier C; Birnbaum D; Reddel RR; Géli V
EMBO Mol Med; 2022 Oct; 14(10):e15859. PubMed ID: 35920001
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas.
Forus A; Weghuis DO; Smeets D; Fodstad O; Myklebost O; Geurts van Kessel A
Genes Chromosomes Cancer; 1995 Sep; 14(1):15-21. PubMed ID: 8527379
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.
Lu XY; Lu Y; Zhao YJ; Jaeweon K; Kang J; Xiao-Nan L; Ge G; Meyer R; Perlaky L; Hicks J; Chintagumpala M; Cai WW; Ladanyi M; Gorlick R; Lau CC; Pati D; Sheldon M; Rao PH
Mol Cancer Res; 2008 Jun; 6(6):937-46. PubMed ID: 18567798
[TBL] [Abstract][Full Text] [Related]
18. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
[TBL] [Abstract][Full Text] [Related]
19. MAPK7 and MAP2K4 as prognostic markers in osteosarcoma.
Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Filho RJ; Juliano Y; Toledo SR
Hum Pathol; 2012 Jul; 43(7):994-1002. PubMed ID: 22154052
[TBL] [Abstract][Full Text] [Related]
20. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
